APP and Alzheimer disease: The transmembrane protein amyloid precursor protein (APP) is mutated in Alzheimer’s disease (AD), which increases the production of β-amyloid peptides (Aβ peptides), particularly Aβ42, which promotes the formation of amyloid aggregates and plaques, leading to early neurodegeneration and dementia [92].